KSM Feed

The corona vaccine also provides protection to celiac patients

KSM is calling for research proposals 2024. Research grants of up to 100K NIS.

New Study Shows Pfizer COVID-19 Vaccine Equally Effective for Patients with Celiac Disease.

COVID-19 Vaccine Protects Against the Corona Virus in Patients with Celiac Disease.

COVID-19 Vaccine Protects Against the Corona Virus in Patients Diagnosed With Celiac.

Celiac sufferers in Maccabi HMO up 600% in less than 20 years, study shows

KSM research ahead Celiac Awareness Day: Celiac diagnoses in kids and teens up over 10-fold.

KSM research ahead of the Celiac Awareness Day: The number of diagnosed patients has increased 6 fold over the last...

Dr. Tal Patalon, Head of KSM, discussing AI at the Ynet health conference today, sharing her vision on technologies that...

Apparently Getting Smarter Makes Us Healthier: AI And Data Analysis Revolutionize Healthcare

The genetic revolution is already here. Are we prepared for it? Dr. Tal Patalon’s, Head of KSM, opinion column on...

Our podcast with the renowned Grammy award winning violinist Miri Ben Ari, featured in the Jerusalem Post, presenting the fascinating...

Maccabi’s KSM Research and Innovation Center ‘Asthma map’: The highest rate of asthma patients in Israel is found in the...

More asthma sufferers live in areas with high levels of pollution

For World Asthma Day, we examined air quality ratios in various geographic locations in Israel, and the prevalence of Asthma...